To study the molecular basis of SLM2-dependent TTN intron inclusion, which we found by SLM2-RIP-seq in DCM patients, we designed a minigene construct consisting of human TTN exons 131–133 (named TTN131–133). This evidence concerns the gene TTN and familial dilated cardiomyopathy.